Adaptive Biotechnologies Corporation
Hedge Funds Holdings
Last updated:
Adaptive Biotechnologies Corporation‘s stocks are currently a part of 194 hedge funds’ portfolios, which represents 86.55% of the total amount of its stocks outstanding. This makes up a total of 123.21M shares of Adaptive Biotechnologies Corporation. Compared to the previous quarter, the number fell by -7.48% or -9.95M shares fewer. As for the holding position changes, 38.14% (74) of current hedge fund investors increased the number of shares held, 27.84% (54) of current holders sold a part of the shares held, and 11.86% (23) closed the holdings completely. 34 hedge funds are new holders of Adaptive Biotechnologies Corporation stock in Q3 2022, it is 17.53% of total holders.
Hedge funds holding Adaptive Biotechnologies (Q4 2017 – Q3 2022)
Q4 2017 | 1 |
---|---|
Q1 2018 | 1 |
Q2 2018 | 1 |
Q3 2018 | 1 |
Q4 2018 | 1 |
Q1 2019 | 2 |
Q2 2019 | 112 |
Q3 2019 | 118 |
Q4 2019 | 132 |
Q1 2020 | 148 |
Q2 2020 | 195 |
Q3 2020 | 206 |
Q4 2020 | 248 |
Q1 2021 | 244 |
Q2 2021 | 227 |
Q3 2021 | 215 |
Q4 2021 | 210 |
Q1 2022 | 215 |
Q2 2022 | 201 |
Q3 2022 | 194 |
Hedge funds changes in Adaptive Biotechnologies positions (Q4 2017 – Q3 2022)
Q4 2017 | 1 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q1 2018 | 0 | 0 | 0 | 0 | 1 |
Q2 2018 | 0 | 0 | 0 | 0 | 1 |
Q3 2018 | 0 | 0 | 0 | 0 | 1 |
Q4 2018 | 0 | 0 | 0 | 0 | 1 |
Q1 2019 | 1 | 0 | 0 | 0 | 1 |
Q2 2019 | 110 | 0 | 0 | 0 | 2 |
Q3 2019 | 51 | 31 | 25 | 45 | -34 |
Q4 2019 | 41 | 44 | 29 | 22 | -4 |
Q1 2020 | 41 | 69 | 24 | 23 | -9 |
Q2 2020 | 60 | 63 | 49 | 13 | 10 |
Q3 2020 | 38 | 96 | 43 | 26 | 3 |
Q4 2020 | 59 | 82 | 80 | 15 | 12 |
Q1 2021 | 45 | 96 | 78 | 48 | -23 |
Q2 2021 | 36 | 98 | 58 | 53 | -18 |
Q3 2021 | 20 | 84 | 62 | 28 | 21 |
Q4 2021 | 24 | 78 | 67 | 28 | 13 |
Q1 2022 | 48 | 87 | 48 | 40 | -8 |
Q2 2022 | 27 | 89 | 56 | 40 | -11 |
Q3 2022 | 34 | 74 | 54 | 23 | 9 |
Hedge funds changes in Adaptive Biotechnologies stock options (Q4 2017 – Q3 2022)
Q4 2017 | 0 | 0 |
---|---|---|
Q1 2018 | 0 | 0 |
Q2 2018 | 0 | 0 |
Q3 2018 | 0 | 0 |
Q4 2018 | 0 | 0 |
Q1 2019 | 0 | 0 |
Q2 2019 | 0 | 0 |
Q3 2019 | 4,777,000 | 3,021,000 |
Q4 2019 | 1,606,000 | 4,989,000 |
Q1 2020 | 2,768,000 | 3,540,000 |
Q2 2020 | 14,070,000 | 7,059,000 |
Q3 2020 | 20,199,000 | 5,305,000 |
Q4 2020 | 28,247,000 | 10,311,000 |
Q1 2021 | 26,068,000 | 27,452,000 |
Q2 2021 | 20,228,000 | 7,792,000 |
Q3 2021 | 6,501,000 | 4,108,000 |
Q4 2021 | 6,411,000 | 1,183,000 |
Q1 2022 | 1,188,000 | 2,092,000 |
Q2 2022 | 1,623,000 | 417,000 |
Q3 2022 | 1,064,000 | 522,000 |